Dr. Elvis L. ONGEY
Cited by
Cited by
Lanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical production
EL Ongey, P Neubauer
Microbial cell factories 15, 1-16, 2016
Pharmacological and pharmacokinetic properties of lanthipeptides undergoing clinical studies
EL Ongey, H Yassi, S Pflugmacher, P Neubauer
Biotechnology letters 39, 473-482, 2017
Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity
M Narwal, J Koivunen, T Haikarainen, E Obaji, OE Legala, ...
Journal of medicinal chemistry 56 (20), 7880-7889, 2013
Bioinspired designs, molecular premise and tools for evaluating the ecological importance of antimicrobial peptides
EL Ongey, S Pflugmacher, P Neubauer
Pharmaceuticals 11 (3), 68, 2018
Type II thioesterase improves heterologous biosynthesis of valinomycin in Escherichia coli
J Li, J Jaitzig, L Theuer, OE Legala, RD Süssmuth, P Neubauer
Journal of Biotechnology 193, 16-22, 2015
Heterologous biosynthesis, modifications and structural characterization of Ruminococcin-A, a lanthipeptide from the gut bacterium Ruminococcus gnavus E1, in Escherichia coli
EL Ongey, RT Giessmann, M Fons, J Rappsilber, L Adrian, P Neubauer
Frontiers in Microbiology 9, 1688, 2018
Bioprocess Development for Lantibiotic Ruminococcin-A Production in Escherichia coli and Kinetic Insights Into LanM Enzymes Catalysis
EL Ongey, L Santolin, S Waldburger, L Adrian, SL Riedel, P Neubauer
Frontiers in Microbiology 10, 2133, 2019
Incorporation of non-canoncical amino acids into recombinant human proteins heterologously expressed in E. coli by bioprocess parturbations
E Ongey
E. Ongey, 2014
Reconstructing the biosynthetic machinery of Ruminococcin A, a lanthipeptide identified from a strictly anaerobic Gram positive bacteria, in E. coli
OE Legala, M Fons, P Neubauer
The system can't perform the operation now. Try again later.
Articles 1–9